Osamu Iwase

508 citations
31 papers · 412 indexed · h-index 10
Topics
Chronic Lymphocytic Leukemia Research (7 papers)Acute Myeloid Leukemia Research (5 papers)Eosinophilic Disorders and Syndromes (4 papers)
Partner nations
JapanUnited States

In The Last Decade

Osamu Iwase

30 papers receiving 403 citations

Peers

Osamu Iwase
Comparison fields: 5 of 68
  • Hematology 214
  • Genetics 136
  • Molecular Biology 82
  • Oncology 70
  • Immunology 62
Replace Judit Várkonyi with:
Judit Várkonyi Hungary
Peihong Zhang China
Shyamala Navada United States
Paulette Jacobs United States
Anna Pitto Italy
Daniel Hormaechea‐Agulla Spain
Chiara Gregorj Italy
Shinya Rai Japan
Anikó Újfalusi Hungary
Rei Asakai Japan
Osamu Iwase relative to Judit Várkonyi Hungary Judit Várkonyi's profile →
Citations per field
00.5×1.5×
Judit Várkonyi · 1×
Citations per year

Countries citing papers authored by Osamu Iwase

Since Specialization
Citations

This map shows the geographic impact of Osamu Iwase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Iwase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Iwase more than expected).

Fields of papers citing papers by Osamu Iwase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Iwase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Iwase. The network helps show where Osamu Iwase may publish in the future.

Co-authorship network of co-authors of Osamu Iwase

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Iwase. A scholar is included among the top collaborators of Osamu Iwase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Iwase. Osamu Iwase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 59
2 0
3 4
4 19
5 3
6 16
7 68
8 1
9 5
10 2
11 1
12 81
13
[Hypereosinophilic syndrome complicated by myelofibrosis].
1
14 40
15 8
16 10
17 4
18 9
19
[Immunocompetent cells in lymph nodes of B-cell lymphomas].
1
20 3

About Osamu Iwase

Osamu Iwase is a scholar working on Hematology, Genetics and Immunology, having authored 31 papers that have together received 412 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Hematology (214 citations), Genetics (136 citations) and Rheumatology (52 citations). Osamu Iwase has collaborated with scholars based in Japan and United States. Frequent co-authors include Shin Aizawa, Masaki Hiramoto, Hiroshi Handa, Makoto Yaguchi, H Hoshi, Ryusuke Nabeshima, Keisuke Toyama, Masaru Nakano, Keisuke Miyazawa and Daisuke Shima. Their work appears in journals such as Blood, Annals of Oncology and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026